Accordingly, in RR-MS patients the CSF levels of IL-1β have been correlated with a paradoxical LTP-like effect in response to an LTD-inducing TMS protocol [41], confirming that this cytokine also produces a profound subversion of synaptic plasticity in human MS. Here, IL1B is linked to myeloid sarcoma.